The importance of hemodynamic factors in the pathogenesis and treatment of cerebrovascular disease remains uncertain. The extracranial-intracranial (EC-IC) bypass trial has been criticized for failing to identify and separately analyze those patients with chronic reduction in regional cerebral perfusion pressure (rCPP) who might be most likely to benefit from surgery. Positron emission tomography (PET) measurements of regional cerebral blood flow (rCBF) and blood volume (rCBV) were performed on 29 patients with symptomatic occlusion or intracranial stenosis of the carotid arterial system prior to undergoing EC-IC bypass surgery. Twenty-four patients had evidence of reduced rCPP (increased rCBV/rCBF ratio) distal to the arterial lesion. Of 21 patients who survived surgery without stroke, three suffered ipsilateral ischemic strokes during the 1 st postoperative year. A nonrandomized control group of 23 nonsurgical patients' with similar clinical, arteriographic, and PET characteristics experienced no ipsilateral ischemic strokes during the 1 st year following PET. Based on these results in 44 patients, the probability that successful surgery reduces the occurrence of ipsilateral ischemic stroke 1 year later was calculated. This probability ranged from 0.045 for a 50% reduction to 0.168 for a 10% reduction. Thus, there was little evidence to suggest that measurements of cerebral hemodynamics can identify a group of patients who would benefit from EC-IC bypass surgery.
T
HE importance of hemodynamic factors in the pathogenesis of ischemic cerebrovascular disease remains unclear. Clarifying this issue is of clinical importance since thromboinhibitory drugs, no matter how effective, can do little to prevent cerebral infarction produced by decreases in regional cerebral perfusion pressure (rCPP) distal to occlusive disease of the carotid or vertebral arterial systems. Surgical revascularization procedures have the potential to improve rCPP and regional cerebral blood flow (rCBF) to such areas and to prevent hemodynamic infarction. Extracranial-intracranial (EC-IC) bypass surgery was developed to improve rCPP in patients with complete carotid occlusion or intracranial carotid stenosis not amenable to conventional endarterectomy.
Since EC-IC surgery is unlikely to provide protection from embolic stroke, its efficacy in preventing stroke should be an indication of the importance of hemodynamic factors in the pathogenesis of cerebral infarction. A large prospective randomized trial has demonstrated no value for this surgery in preventing subsequent stroke. ~2 This trial has been criticized for failing to identify and separately analyze the subgroup of patients with reduction in rCPP distal to the symptomatic arterial lesion who might be most likely to benefit from the surgery.l'9'13 Accurate identification of such patients is not possible from the conventional clinical and arteriographic data collected in the trial. Neither the clinical characteristics of cerebral ischemia nor the degree of carotid stenosis are reliable predictors of cerebral hemodynamic status. 28'3~ The presence of abnormal arteriographic collateral circulation via the ophthalmic artery has been demonstrated to be a specific, although insensitive, indicator of reduced rCPP in the ipsilateral cerebral hemisphere in a series of 19 patients without cerebral infarction. 28 It is not known whether this specificity is maintained if subsequent cerebral infarction occurs and the total blood flow requirement of the hemisphere is reduced. Although subsequent analysis of data from the EC-IC Bypass Trial revealed no difference in outcome between medically and surgically treated patients with carotid occlusion and large oph-thalmic collaterals, 3'4 the specificity of large ophthalmic collateral vessels as indicators of reduced rCPP in this population cannot be assumed since two-thirds of the trial participants had strokes as the event leading to their randomization.
Although sometimes used for this purpose, measurements of rCBF alone are not adequate for defining cerebral hemodynamic status because they cannot distinguish reductions in flow caused by reduction in rCPP from those caused by the reduced metabolic demands of damaged tissue. 29 As a result of these deficiencies in conventional modalities, a variety of other in vivo techniques to assess rCPP more accurately have been developed. All are based on the fact that rCBF autoregulates in response to reduced rCPP by dilation of cerebral vessels. Thus, the increases in rCBF that normally follow vasodilatory stimuli, such as 5% CO2 inhalation or intravenous injection of acetazolamide, are reduced when autoregulatory vasodilation in response to reduced rCPP is already present. 7 ' 23' 35 Similarly, the ratio of regional cerebral blood volume (rCBV) to rCBF measured by positron emission tomography (PET) or single photon emission computerized tomography (SPECT) is elevated when rCPP is reduced. 10"16"17't9'20'26'28 ( The rCBV/rCBF ratio is mathematicaUy equivalent to the mean vascular transit time for red blood cells through the brain, and thus an increase in rCBV/rCBF indicates slowing of the cerebral circulation. 26) Positron emission tomography has the added advantage of not only providing more accurate regional measurements than SPECT, but also of permitting further categorization of the severity of hemodynamic compromise by measuring the regional oxygen extraction fraction (rOEF). 29 When reductions in rCPP are so severe that autoregulation fails, rCBF falls relative to regional cerebral oxygen metabolism (rCMRO2) and rOEF increases. 5,6, ~ 6,26,29 Although PET has been used by several laboratories to demonstrate postoperative improvement of cerebral hemodynamics by EC-IC bypass surgery, 5"~7"z~ no systematic follow-up review of these patients has been reported. In 1981, we began a PET study of candidates for EC-IC bypass with the hypothesis that surgery would reduce ipsilateral ischemic stroke in those with PET evidence of reduced rCPP. This report presents the clinical outcome of 29 patients who were studied by PET prior to EC-IC bypass procedures and were followed for 1 to 6 years thereafter (median 4.25 years). The occurrence of ipsilateral ischemic stroke at 1 year in 21 of these 29 patients who had PET evidence of reduced rCPP preoperatively is compared to the occurrence of ipsilateral stroke in a nonrandomized control group of 23 clinically and angiographically similar patients with the same PET findings who did not undergo cerebrovascular surgery and have been followed for 1 year.
Clinical Material and Methods
From February, 1981, through January, 1987, PET measurements of rCBF, rCBV, and rOEF were performed on 32 patients prior to EC-IC bypass surgery. Thirty patients were operated on at our institution, representing 46% of the 65 patients who underwent EC-IC bypass during that period. Three patients were eliminated from this study because it was impossible to place the required minimum of four standardized regions of interest (see below) in noninfarcted brain of the symptomatic cerebral hemisphere. In one, no skull x-ray film was taken to record the relationship between PET slices and the brain; one had such a large infarct that insufficient noninfarcted brain was left for analysis; and one was positioned in the scanner such that most of the hemisphere was not imaged. The remaining 29 patients form the basis of this report. Twenty-eight were studied prior to publication of the EC-IC Bypass Trial results in 1985. ~2 The single patient studied since then was blind in one eye and underwent bypass surgery in an ultimately unsuccessful attempt to preserve failing vision in her remaining eye affected by low-pressure retinopathy. 18,33 All 29 patients had: 1) angiographically documented occlusion or greater than 50% intracranial stenosis of the carotid or middle cerebral artery; and 2) transient ischemic attacks (TIA's) or mild completed stroke of the brain or retina in the arterial territory distal to the lesion. Three patients had previously undergone cerebrovascular surgery for the same symptoms prior to PET (one with ipsilateral external carotid endarterectomy, one with ipsilateral internal carotid endarterectomy proximal to a severe carotid siphon stenosis, and one with contralateral internal carotid endartectomy). All three had suffered recurrent symptoms postoperatively. Further clinical and angiographic details are given in Table 1 .
The EC-IC bypass surgery was performed a mean of 9.6 days (range 1 to 54 days) after PET. Twenty-one of the 29 patients were operated on within a week. Twentyfive patients underwent only ipsilateral superficial temporal artery (STA)-middle cerebral artery (MCA) anastomosis. Of the remaining four patients, one was treated with ipsilateral external carotid endarterectomy followed by STA-MCA anastomosis, one with external carotid artery-MCA anastomosis and a saphenous vein graft because of a small STA, one with ipsilateral STA-MCA anastomosis followed by contralateral STA-MCA anastomosis 5 months later for asymptomatic carotid artery occlusion, and one with ipsilateral STA-MCA anastomosis followed 2 years later by contralateral internal carotid artery (ICA) endarterectomy for new symptoms of amaurosis fugax.
Two patients had atrial fibrillation. One had an 80% stenosis of the right carotid siphon and suffered multiple transient episodes of left-sided weakness associated with coarse jerking movements of the limbs which occurred only after assumption of an uptight posture. The other had right carotid artery occlusion and ipsilateral low-pressure retinopathy and experienced five episodes of transient left-sided weakness followed by development of persistent mild left-hand weakness.
The control group of 23 patients with reductions in rCPP was drawn from a series of unoperated patients * Stages: 0 = normal hemodynamics; I = reduced regional cerebral perfusion pressure (rCPP); II = reduced rCPP and reduced blood flow.
l" Numbers of patients with only retinal disease (amaurosis fugax or retinal infarction) are listed in parentheses. The number of transient ischemic attacks (TIA) refers to the 3 months preceding positron emission tomography (PET).
Number of days prior to PET. w Most severe angiographic lesion in the middle cerebral artery (MCA) or carotid artery (CA) ipsilateral to the symptoms (sx). Recurrent symptoms indicate those noted after angiographic demonstration of occlusion and prior to PET. studied prior to January, 1987. 3~ All met the following criteria: l) presence of an angiographically documented occlusion or greater than 75% intracranial stenosis of the ICA or MCA (angiography was performed for clinical indications because the attending physician believed each patient to be a good candidate for cerebral revascularization surgery); 2) occurrence of a TIA or mild completed stroke of the brain or retina in the arterial territory distal to the lesion; 3) no cerebrovascular surgery planned that might be expected to alter the cerebral hemodynamic status; and 4) increased rCBV/rCBF ratio in uninfarcted brain in the MCA territory distal to the symptomatic arterial lesion. Six of these patients had undergone cerebrovascular surgery prior to PET; of these, three had ipsilateral external carotid endarterectomies, two had contralateral (asymptomatic) ICA endarterectomies, and one had an ipsilateral carotid endarterectomy for a tandem lesion proximal to a more severe intracranial ICA stenosis. None of these six patients had recurrent symptoms after surgery prior to PET. Further clinical details are given in Table 2 .
The 23 control patients had undergone PET studies for two principal reasons. Nine patients, who were Number of days prior to PET. w Most severe angiographic lesion in the middle cerebral artery (MCA) or carotid artery (CA) ipsilateral to the symptoms (sx). Recurrent symptoms indicate those noted after angiographic demonstration of occlusion and prior to PET. studied prior to mid-1985 when the results of the EC-IC Bypass Trial became known, were investigated as part of a research project to determine the effects of EC-IC bypass surgery on cerebral hemodynamics. 27 Two of these patients declined surgery. The other seven were not operated on primarily because PET did not show increased rOEF in the symptomatic hemisphere (a preoperative finding that correlates well with postoperative improvement in hemispheric CBF5.27.29). Thirteen other patients in the control group are part of a prospective study begun by us in mid-1985 to evaluate the impact of hemodynamic factors on the risk of stroke in patients who formerly would have been considered candidates for EC-IC bypass surgery. The one other patient had undergone PET studies to evaluate a clinically asymptomatic, angiographic subclavian steal.
Follow-up evaluation for all patients was initiated in May, 1987, and was completed in January, 1988. Information on the subsequent occurrence of stroke or death for both surgical and nonsurgical patients was obtained from the subjects, their next of kin, or medical records. Medical records were reviewed for all cases of stroke and either medical records or eyewitness accounts were obtained for all deaths. Stroke was defined as a focal neurological deficit of sudden onset and presumably cerebrovascular origin which lasted longer than 24 hours. Stroke with clinical or computerized tomography (CT) localization in the previously symptomatic arterial territory and no evidence of primary intracranial hemorrhage was classified as ipsilateral ischemic stroke. Perioperative mortality and stroke morbidity were defined as all events occurring within 30 days postoperatively. Three surgical patients were lost to follow-up review at 16, 31, and 39 months after PET. Data for all other surgical patients were obtained until time of stroke, death, or follow-up contact. Clinical follow-up evaluation of 23 patients in the control group is complete to 1 year post-PET. 3~ Since 12 of these patients were studied in 1986, follow-up data for longer periods are not yet available. Thus, clinical follow-up data are complete for all surgical and nonsurgical patients to 1 year post-PET.
Positron Emission Tomography
Measurements of rCBF, rCBV, and rOEF for all patients were performed on the PETT VI tomograph in the low-resolution mode (reconstructed transverse resolution 18 mm FWHM). 37 This tomograph collects seven parallel tomographic slices, 14.4 mm apart. All radiotracers were produced by the Washington University medical cyclotrons. > Informed written consent was obtained from each subject before the PET measurements. This protocol was approved by the Human Studies Committee and the Radioactive Drug Research Committee of the Washington University School of Medicine.
Venous and arterial catheters were placed to permit radiotracer injection and collection of arterial blood samples. The subjects were positioned so that the lowest tomographic slice was near the canthomeatal line. The head was then immobilized by an individualized face mask made of heat-molded plastic that was attached to a headrest. A plastic plate with seven radiopaque wires was used to record the position of each of the seven PET slices on the lateral skull radiograph. A transmission scan with a germanium-68/gallium-68 ring source was performed on each subject to provide data on photon attenuation necessary for quantitative reconstruction of subsequent scans.
Regional cerebral blood flow was measured after rapid intravenous injection of oxygen-15 (~ 50)-labeled water. 32 Regional cerebral blood volume was measured after brief inhalation of 150-labeled carbon monoxide. 2~ The rOEF was measured after brief inhalation of 1sO-labeled oxygen. -~2 The rCMRO2 was calculated as the product of rCBF, rOEF, and arterial oxygen content. -~2 The subjects' eyes and ears were not masked. The short half-life of 150 (123 seconds) allowed these studies to be done in rapid succession. Total study duration ranged from 1 to 2 hours.
For each subject, seven 1.37 x 1.37-cm regions of interest in the cortical territory of the MCA were defined in each hemisphere using stereotaxic coordinates.l>2528 Any regions within areas corresponding to lucencies on x-ray CT scans or within well-demarcated areas of reduced rCMRO2 corresponding to clinical neurological deficits were considered to be infarcted tissue. These regions and homologous regions in the opposite hemisphere were discarded from analysis. The mean value from the remaining regions (minimum four) in each hemisphere was calculated to obtain the rCBV/rCBF ratio and rOEF computation.
The hemodynamic status of the cerebral circulation in the hemisphere ipsilateral to the symptomatic carotid artery lesion was determined based on the rCBV/rCBF ratio and rOEF as described previously. 2~ Absolute values or hemispheric asymmetries outside the normal range obtained from 17 normal subjects aged 18 to 30 years were considered to be abnormal. The patients were divided into three hemodynamic categories according to the PET data: Stage 0 (normal): normal rCBV/rCBF ratio and normal rOEF; Stage I (reduced rCPP, normal flow): increased rCBV/rCBF ratio and normal rOEF; Stage II (reduced flow): increased rCBV/ rCBF ratio and increased rOEF.
Statistical Analysis
Our principal hypothesis was that EC-IC bypass would lead to a reduction in ipsilateral ischemic stroke in patients with PET evidence of reduced rCPP. Since the majority of patients in the nonsurgical control group were studied during 1986, complete follow-up data for this group was only available to 1-year post-PET. This time point was therefore chosen to compare the outcome of surgical and nonsurgical groups with an increased rCBV/rCBF ratio. Due to this short followup period, it is very likely that perioperative morbidity and mortality would cause a poorer result in the surgical group, regardless of any longer-term surgical benefit. For the purpose of this report, therefore, if was elected to eliminate surgical morbidity and mortality from the analysis and only consider those patients who survived surgery without a stroke. We fully realize that by doing this we are determining the benefit of a successful operation and not analyzing the effect of choosing surgical therapy. The small numbers and short followup period in this study preclude any meaningful use of life-table analysis for comparing outcome in these two groups. We have simply compared the stroke occurrence within 1 year in surgical and nonsurgical groups with chi-square analysis. This has allowed us to apply the method of Dunnett and Gent ~1 to our data and to compute the probabilities that successful performance of EC-IC bypass surgery actually leads to a reduction in ipsilateral ischemic stroke of 10%, 25%, or 50% at 1 year in patients with PET evidence of reduced rCPP.
Results
Based on PET measurements in the MCA territory distal to the symptomatic carotid artery or MCA, as shown in Table l , five surgical patients had normal hemodynamics (Stage 0) and 24 had reduced rCPP identified by an increase in the rCBV/rCBF ratio (Stage I and II); 10 of these 24 also had increases in rOEF (Stage II). Early graft patency was assessed within 2 weeks following surgery in all but one patient, who had an angiographically patent graft 34 months later. In 23 of 29 patients, postoperative arteriography was performed. In the six who refused arteriography, graft patency was assessed by Doppler flow measurement in four and pulse palpation in the remaining two. The overall patency rate was 93% (27 of 29 cases). Both patients with early nonpatency suffered postoperative strokes (see below).
There was one postoperative death due to myocardial infarction in a Stage I patient. There were three postoperative strokes, one each in Stage 0, I, and II patients. All occurred in the hemisphere ipsilateral to the bypass. Two of the strokes were evident when the patients awoke from surgery and the other developed within 24 hours postoperatively. At discharge, two of these patients had moderate residual neurological deficits (foot weakness or aphasia) and the third had largely recovered from an episode of right-hand weakness and aphasia. During the follow-up period, three deaths and three nonfatal strokes occurred. One patient (Stage II) All three nonfatal strokes occurred within I year post-PET. Preoperatively, all three patients had exhibited PET evidence of reduced rCPP distal to an occluded carotid artery: one had only elevation of the rCBV/ rCBF ratio (Stage I) and two had elevated rOEF as well (Stage II). All three patients had had multiple hemispheric TIA's and two also had ipsilateral low-pressure retinopathy. After EC-IC bypass surgery, repeat PET measurements in all three patients had demonstrated hemodynamic improvement but not normalization. There was a reduction in the asymmetry of the rCBV/ rCBF ratio in all three and return of rOEF to normal in the two patients in whom it had been elevated preoperatively. Postoperative arteriography in two patients showed filling of the MCA system and distal ICA by the bypass. The third patient refused arteriography, but flow through the bypass was demonstrated by Doppler ultrasonography prior to her discharge. Ischemic stroke in the MCA territory ipsilateral to the EC-IC bypass developed l, 4, and 7 months postoperatively.
The onset was sudden in one episode, and in two there was a gradual or stepwise progression over several weeks. In these three cases, CT lucencies were demonstrated in the ipsilateral caudate and perisylvian regions, the anterior cerebral artery and anterior and posterior MCA watershed regions, and the frontoparietal region, respectively. Arteriography following stroke revealed the bypass grafts to be patent in all three patients but with little or no filling of the MCA branches in two. All were taking aspirin and dipyridamole at the time the stroke occurred.
Disregarding perioperative morbidity and mortality, the ipsilateral ischemic stroke incidence within 1 year in patients with PET evidence of impaired cerebral hemodynamics preoperatively who survived surgery without stroke was three of 21 patients (two of nine patients with increased rOEF). There were no cases of ipsilateral ischemic stroke in 23 unoperated control patients with the same PET findings, six of whom had increased rOEF). The clinical and angiographic characteristics at the time of the initial PET for all 44 patients are given in Table 2 . The difference in stroke occurrence between the two groups is not statistically significant (p = 0.201). Based on these data, the probability that successfully performed EC-IC bypass actually produces a reduction in ipsilateral ischemic stroke at 1 year was calculated for three different degrees of reduction. The probability of a 50% reduction is 0.045, that of a 25% reduction is 0.119, and that of a 10% reduction is 0.168.
Discussion
This study has compared the occurrence of ipsilateral ischemic stroke within 1 year postoperatively in 21 patients with PET evidence of hemodynamic cerebrovascular disease who successfully underwent EC-IC bypass to that in 23 patients with the same PET findings who did not undergo surgery. Our analysis was restricted to ipsilateral ischemic stroke since the investigation was of the effects of surgery designed to improve local hemodynamics in patients with ipsilateral reductions in rCPP. For the purpose of this analysis, surgical morbidity and mortality was ignored because it would unfairly prejudice the outcome against surgery at this early time interval. Nevertheless, the surgical group fared worse, with three of the 21 patients with surgery having ipsilateral ischemic strokes during the 1 st year versus none of the 23 patients in the nonsurgical group. While this difference was not statistically significant (p = 0.201), the aim of surgical therapy is not to provide equivalence but to provide benefit. Given these results in our sample of 44 patients, the probability that successful surgery actually confers benefit was calculated and found to be very small, ranging from 0.045 for a 50% reduction in ipsilateral ischemic stroke at 1 year to 0.168 for a 10% reduction.
The ability to generalize from any conclusions about the value of EC-IC bypass from our data depends to a great degree on the comparability of the surgical and nonsurgical groups. This was not a randomized trial and, as such, suffers from the potential for selection bias in choosing therapeutic regimens. Although the two groups were well matched in terms of epidemiological risk factors (age, sex, and presence of hypertension, diabetes, and heart disease) and type of medical therapy (Table 2) , they differed in several clinical aspects. In the surgical group, more patients had TIA's, more had multiple (more than six) TIA's, fewer had ICA occlusion without recurrent symptoms, and more had symptoms within 30 days prior to study entry. Although these differences may affect prognosis, each of these factors was analyzed in the EC-IC Bypass Trial and none identified a subgroup of patients who benefited from surgery. 3'4A2 We have similarly tested cerebral hemodynamics as a single independent factor and found no evidence that it can be used to select patients for surgery. A much larger randomized study would be needed to determine if hemodynamic status in combination with other clinical or epidemiological factors can identify a subgroup of patients who would benefit from EC-IC bypass.
Three of the four strokes we recorded during the follow-up period occurred during the 1 st year. This is consistent with data reported by Sundt, et al., 36 who found a higher risk of stroke in the first 6 months after EC-IC bypass surgery than in the ensuing 3 years. A similar trend is evident from the graphs published in the report of the EC-IC Bypass Trial.12 Since we only have adequate follow-up data for our control group to 1 year, we are not able to comment on any comparison between medical and surgical therapy at longer intervals when the rate of stroke for both groups is likely to be less. 8, 12, 36 Given the failure of EC-IC bypass placement to prevent ipsilateral ischemic stroke in three patients with PET evidence of reduced rCPP, some consideration of the possible mechanism of stroke in these individuals is warranted. Positron emission tomography studies of the results of EC-IC bypass surgery have demonstrated that the surgery improves cerebral hemodynamic status but may not return it to nornlal. 5A7'2~ Such was the case in these three patients. We do not believe failure to completely normalize cerebral hemodynamics is the explanation for the subsequent occurrence of stroke, however. In a study of medically treated patients studied by PET, no evidence was found that abnormal cerebral hemodynamics identified a subgroup of patients at increased risk for early stroke. 3~ Furthermore, in the analysis of the EC-IC Bypass Trial no difference in stroke occurrence was found in medically treated patients with carotid occlusion who had good, fair, or poor collateral circulation. 3'4 Late graft occlusion was not the cause of stroke since it was demonstrated that all three grafts were still patent. Differentiation between hemodynamic and embolic causes of stroke based on clinical and radiographic criteria is uncertain since there is no reference standard for either diagnosis to permit validation of such criteria. Two of our patients had prolonged stuttering courses that are believed to be atypical for embolic stroke; ~4 one of these had infarcts in the MCA watershed territories anteriorly and posteriorly, suggesting a hemodynamic cause. The third had a more abrupt onset of deficit in the setting of atrial fibrillation. However, in this case, the infarct occurred distal to an occluded ICA and a stenotic external carotid artery and involved the same body parts (face and hand) as several of her TIA's prior to surgery. The actual mechanism of these strokes must remain uncertain.
The role of hemodynamic factors in the pathogenesis and treatment of stroke has been the subject of controversy for many years. This study has not demonstrated that surgical therapy which improves cerebral hemodynamic status is likely to have any effect on the subsequent occurrence of stroke in patients with chronic reductions in rCPP. It strongly suggests that hemodynamic factors play, at most, a minor role in the pathogenesis of stroke. However, no single study can provide a definitive answer to this question. The criterion of an abnormal rCBV/rCBF ratio that we used to define abnormal cerebral hemodynamics may not be restrictive enough. In our experience, one-half of patients with 50% or more carotid artery stenosis and three-quarters of patients with carotid artery occlusion will demonstrate this finding by PET. 28'3~ Since patients with these degrees of vascular disease comprise approximately 50% and 15%, respectively, of those with carotid TIA's or stroke, 2' 24"38 we have selected a subgroup that consists of about one-third of all such patients. A smaller subgroup of patients with an even more severe hemodynamic abnormality, such as those with increased rOEF (which we expect to occur in less than 10% of all symptomatic patients), may benefit from cerebral revascularization. We did not have enough patients in this category (10 surgical and six nonsurgical) to test this hypothesis.
To our knowledge, no other information relating measurements of cerebral hemodynamics to subsequent stroke occurrence in surgical and nonsurgical patients is available. Therefore, in the absence of data to the contrary, we do not believe that the use of PET or any other technique that is based on detecting autoregulatory vasodilation can be justified at this time as a clinical means to select patients for cerebrovascular revascularization by EC-IC bypass or any other surgical procedure.
